Appropriate dosing of sugammadex for reversal of rocuronium-/vecuronium-induced muscle relaxation in morbidly obese patients: a meta-analysis of randomized controlled trials. [PDF]
Liao JQ, Shih D, Lin TY, Lee M, Lu CW.
europepmc +1 more source
Sugammadex in systemic mastocytosis : Case report and a systematic review of literature. [PDF]
Becerra-Bolaños A +3 more
europepmc +1 more source
Median effective dose of rocuronium for the prevention of succinylcholine-induced fasciculation: an age-stratified study. [PDF]
Tian S +7 more
europepmc +1 more source
Rocuronium 0.3 or 0.9 mg/kg comparing onset time, duration of action, and intubating conditions in patients 80 years and older: A randomized study. [PDF]
Vested M +8 more
europepmc +1 more source
Failure of neuromuscular blockade despite high doses of rocuronium and atracurium in a patient with colorectal carcinoma: A case report. [PDF]
Dos Santos Rocha A +5 more
europepmc +1 more source
Reversal of neuromuscular blockade with sugammadex based on the residual amount of rocuronium in the body using pharmacokinetic simulation: A single-centre observational study. [PDF]
Morita T +4 more
europepmc +1 more source
Rate of residual neuromuscular block using single-dose rocuronium in general anesthesia for ENT surgery: a retrospective cohort study. [PDF]
Carrillo-Torres O +5 more
europepmc +1 more source
Comparison of reversal of rocuronium-induced neuromuscular blockade with sugammadex under remimazolam versus propofol anesthesia: a randomized clinical trial. [PDF]
Kawasaki T, Fujimoto M, Hirata N.
europepmc +1 more source
Effects of magnesium sulphate on the onset time of rocuronium at different doses: a randomized clinical trial. [PDF]
Almeida CED +5 more
europepmc +1 more source
Occurrence of hemodynamic changes following administration of rocuronium in a dog presenting for an ophthalmic procedure. [PDF]
Calus M, Muñoz KA.
europepmc +1 more source

